Although numerous options have been developed over the last years, including miRNAs, lncRNAs, SNPs and various signaling molecules from both patients’ serum and tumor tissue, CA19-9 and CEA remain the most applied prognostic biomarkers. The gene discussed is CEACAM5; the disease is neoplasm.